Healthcare -
Biotechnology - NASDAQ - US
$ 0.2676
-6.95 %
$ 17.3 M
Market Cap
-0.43
P/E
GLYC - STOCK-BASED COMPENSATION
Stock-based Compensation GLYC - GlycoMimetics, Inc.
3.56 M
LAST VALUE
-23.52%
2 YEAR CAGR
-4.94%
5 YEAR CAGR
23.66%
10 YEAR CAGR